Evidence map›Paper›PMID 42450314›Full record

ArticleInternational journal of molecular sciences2026

Novel Squaramides and Squaramates Containing a Five-Membered Heterocyclic Ring: Synthesis, Structure, and Cytotoxicity.

Georgi Tirolski, Boris Vasilev, Mariyana Atanasova, Georgi Momekov, Hristina Sbirkova-Dimitrova, Adriana Bakalova, Emiliya Cherneva

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Georgi TirolskiDepartment of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Dunav 2 Street, 1000 Sofia, Bulgaria.
Boris VasilevDepartment of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Dunav 2 Street, 1000 Sofia, Bulgaria.
Mariyana AtanasovaDepartment of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Dunav 2 Street, 1000 Sofia, Bulgaria.ORCID 0000-0001-9761-0355
Georgi MomekovDepartment of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Dunav 2 Street, 1000 Sofia, Bulgaria.ORCID 0000-0003-2841-7089
Hristina Sbirkova-DimitrovaInstitute of Mineralogy and Crystallography "Acad. Ivan Kostov", Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Build. 107, 1113 Sofia, Bulgaria.ORCID 0000-0002-0296-7229
Adriana BakalovaDepartment of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Dunav 2 Street, 1000 Sofia, Bulgaria.ORCID 0000-0002-3017-3258
Emiliya ChernevaDepartment of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Dunav 2 Street, 1000 Sofia, Bulgaria.ORCID 0000-0002-1097-1850

Funding

the European Union through the European Structural and Investment funds ( BG16RFPR002-1.014-0018-C01
6 · The paper itself

Abstract

With the introduction of Navarixin in clinical trials, the role of squaric acid derivatives as bioisosteres gained popularity. Because of their distinctive electronic properties and hydrogen-bonding capacity, these compounds hold considerable promise for medicinal chemistry applications. In this study, a series of novel furan- and thiophene-containing squaric acid derivatives was synthesized via base-catalyzed nucleophilic substitution and characterized by spectroscopic techniques. The structures of three compounds were additionally confirmed by X-ray crystallography. Density functional theory calculations showed good agreement with the experimental vibrational spectra. In silico evaluation predicted favorable drug-like characteristics, including compliance with Lipinski's rule of five and high gastrointestinal absorption. The cytotoxic activity of the synthesized compounds was assessed against HeLa, HT-29, HL-60, A-549, and MCF-7 cancer cell lines, as well as the non-cancerous CCL-1 cell line. Several derivatives displayed moderate to strong antiproliferative activity with selectivity toward malignant cells. Compound

Indexed as

Antineoplastic AgentsCyclobutanesHeterocyclic CompoundsCell Line, TumorCell ProliferationCrystallography, X-RayDrug Screening Assays, AntitumorHL-60 CellsHumansMolecular StructureQuinineStructure-Activity RelationshipAntineoplastic AgentsCyclobutanesHeterocyclic CompoundsQuininesquaramidesquaric acidcytotoxic activityNavarixinsquaramatesquaramidesquaric acid

Identifiers

PMID42450314
PMCPMC13361079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.